Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Displaying 1015 questions Show Answers

Order by |

Question reference: S4W-30498

Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Tuesday, 08 March 2016
Current Status: Answered by Jamie Hepburn on 16 March 2016

To ask the Scottish Government whether it will review residential care for people with neurological conditions to identify how many people are placed inappropriately in older people's care homes rather than specialist residential care.

The Scottish Government wants to see people receiving care in their own homes or as close to home as possible, as set out in our recently published clinical strategy. The care being delivered should be appropriate and based on their needs.

It is the responsibility of local authorities to determine the level of services that are required to meet local care needs and to arrange an appropriate range of services to meet individual care needs.

However, we appreciate the challenges of caring for people with complex and round the clock needs. We are determined that people with these kind of conditions get the support they need.

We are joining up health and social care services. This will ensure that our health boards work seamlessly with local authorities to deliver the best possible care, in the right place at the right time. We are also investing a further £250 million per year through health and social care partnerships to protect and grow our social care services.

Question reference: S4W-30333

Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Thursday, 03 March 2016
Current Status: Answered by Jamie Hepburn on 15 March 2016

To ask the Scottish Government what standards are in place for neurological care and whether it plans to change them.

Question reference: S4W-29958

Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Monday, 15 February 2016
Current Status: Answered by Shona Robison on 3 March 2016

To ask the Scottish Government what influence the Macmillan Cancer Support programme, Transforming Care After Treatment, has on the (a) NHS and (b) social care system.

In 2013, the Scottish Government in partnership with Macmillan Cancer Support launched the five year Transforming Care after Treatment programme to support people who have been diagnosed or treated for cancer by integrating health and social care elements to more effectively meet their needs.

As the programme is still ongoing it is not possible to evaluate its influence at this stage. We expect an interim progress report on the programme to be available this summer with a final report due in 2018.

Question reference: S4W-29960

Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Monday, 15 February 2016
Current Status: Answered by Shona Robison on 3 March 2016

To ask the Scottish Government how it ensures that cancer patients are able to provide full feedback about their care and support.

It is essential that we listen to people with cancer in order to fully understand their experiences and what matters most to them.

In October 2015 we launched the first-ever Scottish cancer patient experience survey in partnership with Macmillan Cancer Support. The survey asks people questions such as how they felt about the way that they were told about their diagnosis, whether they understood the information provided about their treatment and whether they had confidence and trust in the staff treating them. The results of this survey, expected in summer 2016, will be helpful in improving on the quality of care available to people living with and beyond cancer.

A new cancer plan will be published in spring 2016, prior to the dissolution of the Scottish Parliament.

Question reference: S4W-29959

Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Monday, 15 February 2016
Current Status: Answered by Shona Robison on 3 March 2016

To ask the Scottish Government how it ensures that the (a) emotional, (b) practical, (c) financial and (d) physical needs of cancer patients are fully assessed.

The Transforming Care After Treatment (TCAT) programme, delivered in partnership with Macmillan Cancer Support, NHS Scotland and local authorities, aims to support and enable people living with and beyond cancer to live as healthy a life as possible for as long as possible.

In February 2016 we also announced £450,000 investment for Macmillan Benefits Services which supports people with cancer, their families and carers to access benefits, claim grants and other related issues.

We will continue to support TCAT and other programmes to improve patient experience and outcomes. A new cancer plan will be published in spring 2016, prior to the dissolution of the Scottish Parliament.

Question reference: S4W-29679

Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 03 February 2016
Current Status: Answered by Maureen Watt on 26 February 2016

To ask the Scottish Government what lifestyle advice and support it makes available to people when attending breast screenings.

Question reference: S4W-29678

Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 03 February 2016
Current Status: Answered by Shona Robison on 26 February 2016

To ask the Scottish Government whether it will provide an update on what progress the Detect Cancer Early Programme is making in meeting its objectives.

Question reference: S4W-29677

Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 03 February 2016
Current Status: Answered by Shona Robison on 26 February 2016

To ask the Scottish Government how much funding it allocates to improve access to life-extending medicines.

Question reference: S4O-05616

Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 24 February 2016
Current Status: Taken in the Chamber on 3 March 2016

To ask the Scottish Government when it will make a final decision on a deposit return scheme for beverage containers.

Question reference: S4W-29680

Asked by: Jackson Carlaw, MSP for West Scotland, Scottish Conservative and Unionist Party
Date lodged: Wednesday, 03 February 2016
Current Status: Answered by Jamie Hepburn on 22 February 2016

To ask the Scottish Government what action it is taking to encourage more clinicians to participate in breast cancer research.

To ensure there is sufficient clinician time to plan and undertake research, the Scottish Government Health and Social Care Research Strategy launched in October 2015 committed to investing £12.7 million per annum to health boards through a researcher support budget to meet the time of staff conducting research.

The NHS Research Scotland Career Researcher scheme was launched in 2011 to support NHS-funded clinical staff in developing a research career within their NHS post. The award provides funding for protected time to contribute to, conduct and lead clinical research. In 2015-16, the Scottish Government provided funding of £1.64 million to support this scheme.

The Scottish Government Chief Scientist Office and Breast Cancer Now have jointly committed a total of £450,000 to be made available for Scottish-led research in breast cancer. This funding covers translational research, defined as having a clear potential pathway to patient benefit.